Multi-level considerations for optimal implementation of long-acting injectable antiretroviral therapy to treat people living with HIV: perspectives of health care providers participating in phase 3 trials
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6963
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Multi-level considerations for optimal implementation of long-acting injectable antiretroviral therapy to treat people living with HIV: perspectives of health care providers participating in phase 3 trials ; volume:21 ; number:1 ; day:20 ; month:3 ; year:2021 ; pages:1-14 ; date:12.2021
BMC health services research ; 21, Heft 1 (20.3.2021), 1-14, 12.2021
- Urheber
-
Mantsios, Andrea
Murray, Miranda
Karver, Tahilin S.
Davis, Wendy
Galai, Noya
Kumar, Princy
Swindells, Susan
Bredeek, U. Fritz
García, Rafael Rubio
Antela, Antonio
Gomis, Santiago Cenoz
Bernáldez, Miguel Pascual
Czarnogorski, Maggie
Hudson, Krischan
Walters, Nicki
Kerrigan, Deanna
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12913-021-06214-9
- URN
-
urn:nbn:de:101:1-2021050616015114583548
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mantsios, Andrea
- Murray, Miranda
- Karver, Tahilin S.
- Davis, Wendy
- Galai, Noya
- Kumar, Princy
- Swindells, Susan
- Bredeek, U. Fritz
- García, Rafael Rubio
- Antela, Antonio
- Gomis, Santiago Cenoz
- Bernáldez, Miguel Pascual
- Czarnogorski, Maggie
- Hudson, Krischan
- Walters, Nicki
- Kerrigan, Deanna
- SpringerLink (Online service)
Ähnliche Objekte (12)
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs
Attitudes of European physicians towards the use of long-acting injectable antipsychotics
Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
Long-Acting Injectable Antipsychotics in a Prescription Claims Data Source: A Validation Study
Improvement of long-term outcome in schizophrenia: switching to risperidone long-acting injectable
Engagement in Care, Awareness, and Interest in Long-Acting Injectable Anti-Retroviral Therapy
Long-Acting Reversible Contraception
Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals: HPTN 077
Assessing readiness to implement long-acting injectable HIV antiretroviral therapy: provider and staff perspectives
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs
Attitudes of European physicians towards the use of long-acting injectable antipsychotics
Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
Long-Acting Injectable Antipsychotics in a Prescription Claims Data Source: A Validation Study
Improvement of long-term outcome in schizophrenia: switching to risperidone long-acting injectable
Engagement in Care, Awareness, and Interest in Long-Acting Injectable Anti-Retroviral Therapy
Long-Acting Reversible Contraception
Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals: HPTN 077
Assessing readiness to implement long-acting injectable HIV antiretroviral therapy: provider and staff perspectives
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs
Attitudes of European physicians towards the use of long-acting injectable antipsychotics
Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
Long-Acting Injectable Antipsychotics in a Prescription Claims Data Source: A Validation Study
Improvement of long-term outcome in schizophrenia: switching to risperidone long-acting injectable
Engagement in Care, Awareness, and Interest in Long-Acting Injectable Anti-Retroviral Therapy
Long-Acting Reversible Contraception
Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals: HPTN 077